23 April 2018
SpeeDx and Serosep sign UK and Ireland distribution agreement
SpeeDx has announced a distribution agreement with Serosep Ltd, a leading manufacturer and distributor of laboratory diagnostic solutions. This will...
19 April 2018
SpeeDx receives FDA listing for Mycoplasma genitalium product
SpeeDx’s ResistancePlus® MG Positive Control kit has now been listed with the US Food and Drug Administration (FDA) for sale...
23 March 2018
Updated guidelines for M. genitalium recommend resistance testing
The Australian STI management guidelines have been updated and now suggest when testing for Mycoplasma genitalium that inclusion of macrolide...
23 February 2018
TGA approval for SpeeDx PlexPCR® VHS | HSV-1&2, VZV & TP |
SpeeDx Multiplexed VZV, Herpes, Syphilis Assay is now fully registered as an IVD in the Australian market. The single-well test is...
25 January 2018
New test developed for virulent STI
You may have never heard of it, but Mycoplasma genitalium - MG for short - is one of the most...
22 January 2018
Mycoplasma genitalium is thought to affect about 400,000 Australians…
…but many people have never heard of it. The bacterium can cause painful urination, itching and bleeding in the rectum,...
